Literature DB >> 21718299

Adiponectin receptor signalling in the brain.

John Thundyil1, Dale Pavlovski, Christopher G Sobey, Thiruma V Arumugam.   

Abstract

Adiponectin is an important adipocyte-derived hormone that regulates metabolism of lipids and glucose, and its receptors (AdipoR1, AdipoR2, T-cadherin) appear to exert actions in peripheral tissues by activating the AMP-activated protein kinase, p38-MAPK, PPARα and NF-kappa B. Adiponectin has been shown to exert a wide range of biological functions that could elicit different effects, depending on the target organ and the biological milieu. There is substantial evidence to suggest that adiponectin receptors are expressed widely in the brain. Their expression has been detected in regions of the mouse hypothalamus, brainstem, cortical neurons and endothelial cells, as well as in whole brain and pituitary extracts. While there is now considerable evidence for the presence of adiponectin and its receptors in the brain, their precise roles in brain diseases still remain unclear. Only a few research studies have looked at this facet of adiponectins in brain disorders. This brief review will describe the evidence for important functions by adiponectin, its structure and known actions, evidence for expression of AdipoRs in the brain, their involvement in brain disorders and the therapeutic potential of agents that could modify AdipoR signalling.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21718299      PMCID: PMC3268187          DOI: 10.1111/j.1476-5381.2011.01560.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  178 in total

Review 1.  Adiponectin--a key adipokine in the metabolic syndrome.

Authors:  J P Whitehead; A A Richards; I J Hickman; G A Macdonald; J B Prins
Journal:  Diabetes Obes Metab       Date:  2006-05       Impact factor: 6.577

2.  Globular adiponectin activates nuclear factor-kappaB in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes.

Authors:  Yoshiyuki Hattori; Sachiko Hattori; Kikuo Kasai
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

Review 3.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

4.  Adiponectin acts in the brain to decrease body weight.

Authors:  Yong Qi; Nobuhiko Takahashi; Stanley M Hileman; Hiralben R Patel; Anders H Berg; Utpal B Pajvani; Philipp E Scherer; Rexford S Ahima
Journal:  Nat Med       Date:  2004-04-11       Impact factor: 53.440

5.  Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.

Authors:  Dorte Glintborg; Jan Frystyk; Kurt Højlund; Kristian Kjaer Andersen; Jan Erik Henriksen; Anne Pernille Hermann; Claus Hagen; Allan Flyvbjerg; Marianne Andersen
Journal:  Clin Endocrinol (Oxf)       Date:  2007-09-04       Impact factor: 3.478

Review 6.  Adiponectin: an update.

Authors:  M Guerre-Millo
Journal:  Diabetes Metab       Date:  2008-02       Impact factor: 6.041

7.  Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients.

Authors:  L Alberti; L Gilardini; A Girola; M Moro; F Cavagnini; C Invitti
Journal:  Diabetes Obes Metab       Date:  2007-05       Impact factor: 6.577

8.  Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin.

Authors:  Fred Haugen; Christian A Drevon
Journal:  Endocrinology       Date:  2007-08-16       Impact factor: 4.736

9.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

Authors:  Ebba Bråkenhielm; Niina Veitonmäki; Renhai Cao; Shinji Kihara; Yuji Matsuzawa; Boris Zhivotovsky; Tohru Funahashi; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  93 in total

1.  Plasma biomarkers for neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Ryan D Geraets; Krystal L Weber; Chun-Hung Chan; David A Pearce
Journal:  FEBS J       Date:  2015-12-17       Impact factor: 5.542

2.  AdipoR1 and 2 are expressed on warm sensitive neurons of the hypothalamic preoptic area and contribute to central hyperthermic effects of adiponectin.

Authors:  Izabella Klein; Manuel Sanchez-Alavez; Iustin Tabarean; Jean Schaefer; Kristina H Holmberg; Joe Klaus; Fengcheng Xia; Maria Cecilia Garibaldi Marcondes; Jeffrey S Dubins; Brad Morrison; Viktor Zhukov; Alejandro Sanchez-Gonzalez; Kayo Mitsukawa; John R Hadcock; Tamas Bartfai; Bruno Conti
Journal:  Brain Res       Date:  2011-09-17       Impact factor: 3.252

3.  Metabolic influences on reproduction: adiponectin attenuates GnRH neuronal activity in female mice.

Authors:  Ulrike Klenke; Carol Taylor-Burds; Susan Wray
Journal:  Endocrinology       Date:  2014-02-24       Impact factor: 4.736

4.  Insulin and adipokine signaling and their cross-regulation in postmortem human brain.

Authors:  Hoau-Yan Wang; Ana W Capuano; Amber Khan; Zhe Pei; Kuo-Chieh Lee; David A Bennett; Rexford S Ahima; Steven E Arnold; Zoe Arvanitakis
Journal:  Neurobiol Aging       Date:  2019-08-20       Impact factor: 4.673

5.  Regulation of arcuate genes by developmental exposures to endocrine-disrupting compounds in female rats.

Authors:  Troy A Roepke; Jennifer A Yang; Ali Yasrebi; Kyle J Mamounis; Elif Oruc; Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Reprod Toxicol       Date:  2016-04-19       Impact factor: 3.143

6.  Ictal adipokines are associated with pain severity and treatment response in episodic migraine.

Authors:  Nu Cindy Chai; Bizu Gelaye; Gretchen E Tietjen; Paul D Dash; Barbara A Gower; Linda W White; Thomas N Ward; Ann I Scher; B Lee Peterlin
Journal:  Neurology       Date:  2015-03-06       Impact factor: 9.910

7.  ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.

Authors:  Seung J Chung; Ganji Purnachandra Nagaraju; Arumugam Nagalingam; Nethaji Muniraj; Panjamurthy Kuppusamy; Alyssa Walker; Juhyung Woo; Balázs Győrffy; Ed Gabrielson; Neeraj K Saxena; Dipali Sharma
Journal:  Autophagy       Date:  2017-07-11       Impact factor: 16.016

8.  Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial.

Authors:  B Lee Peterlin; Gretchen E Tietjen; Barbara A Gower; Thomas N Ward; Stewart J Tepper; Linda W White; Paul D Dash; Edward R Hammond; Jennifer A Haythornthwaite
Journal:  Headache       Date:  2013-03       Impact factor: 5.887

9.  Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway.

Authors:  Zhong Q Wang; Xian H Zhang; Yongmei Yu; Russell C Tipton; Ilya Raskin; David Ribnicky; William Johnson; William T Cefalu
Journal:  Metabolism       Date:  2013-05-21       Impact factor: 8.694

10.  Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage.

Authors:  Anna Perri; Donatella Vizza; Simona Lupinacci; Giuseppina Toteda; Francesca De Amicis; Francesca Leone; Paolo Gigliotti; Danilo Lofaro; Antonella La Russa; Renzo Bonofiglio
Journal:  J Nephrol       Date:  2015-07-28       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.